US Earnings Financial Results SEC Filings — August 04, 2026

04-08-2026

Integer Holdings Corp reported mixed results for Q2 and H1 2026. Sales declined 2.6% YoY to $464.1M in Q2 and 1.1% to $903.7M in H1, while operating income fell 41.8% YoY to $34.5M in Q2 and 39.0% to $66.4M in H1, pressured by higher restructuring charges and SG&A costs. However, net income for H1 rose 176.2% to $40.1M from $14.5M a year ago, aided by a $46.7M debt conversion expense in the prior period. Cash from operations improved to $84.4M in H1 2026 from $75.1M in H1 2025, and the company repurchased $50.0M of common stock during the six months.

• · Restructuring and other charges increased to $9.4M in Q2 2026 from $2.7M in Q2 2025.
• · Non-cash fixed asset impairment of $5.9M recorded in H1 2026.
• · SG&A expenses rose 9.0% YoY to $57.7M in Q2 2026.
• · Inventories increased $36.8M in H1 2026, a significant cash use.
• · Long-term debt increased to $1.24B from $1.19B at year-end 2025.
• · Treasury stock repurchases totaled $50.3M in H1 2026.
• · Goodwill decreased slightly to $1.10B from $1.11B.
• · Accumulated other comprehensive income swung to a loss of $19.5M in H1 2026 from a gain of $77.9M in H1 2025, driven by foreign currency translation.
• · Acquisitions of Precision, VSi, and Biocoat had a combined fair value of net assets acquired of $192.4M.

04-08-2026

Rithm Capital Corp. reported a sharp decline in net income attributable to common stockholders for Q2 2026, falling 92.9% YoY to $20.2M from $283.9M, driven by a $392.9M negative change in fair value of MSRs and MSR financing receivables. Total assets grew 2.0% to $54.1B, and total stockholders' equity increased 1.2% to $9.1B. However, the company's servicing revenue net dropped 47.2% YoY, and total expenses rose 34.0% YoY, significantly outpacing revenue growth of 5.1%.

• · Net income per share (basic) fell to $0.04 in Q2 2026 from $0.54 in Q2 2025.
• · Dividends declared per common share remained unchanged at $0.25 per quarter.
• · Interest income was nearly flat at $474.6M in Q2 2026 vs $478.5M in Q2 2025.
• · Gain on originated residential mortgage loans, held-for-sale increased 22.0% YoY to $207.0M.
• · Asset management revenue grew 49.7% YoY to $142.2M.
• · Commercial real estate revenue was $182.1M in Q2 2026 vs $0 in Q2 2025.
• · Cash, cash equivalents and restricted cash decreased 7.6% to $2.45B from $2.66B at year-end 2025.
• · Accumulated deficit widened to $(226.4M) from $(19.9M) at Dec 31, 2025.
• · Net cash provided by operating activities fell 68.2% to $274.8M for H1 2026 from $864.2M for H1 2025.
• · Net cash used in investing activities was $1.97B in H1 2026 vs net cash provided of $596.7M in H1 2025.

04-08-2026

Voyager Technologies reported a net loss of $46.5M for Q2 2026, widening from a $31.4M loss in Q2 2025, as revenue grew 15.5% to $52.7M but gross profit fell 45.7% due to soaring cost of sales. Operating expenses surged, particularly R&D which jumped from $0.5M to $7.3M, driving operating loss to $51.4M. Cash and equivalents declined 24% to $373.4M from $491.3M at year-end 2025, with operating cash flow negative $84M in the first half.

• · Net loss per share improved to -$0.79 in Q2 2026 from -$1.23 in Q2 2025 due to increased share count.
• · Weighted-average basic shares outstanding more than doubled to 58.5M in Q2 2026 from 29.7M in Q2 2025.
• · Convertible notes remained nearly flat at $448.9M as of June 30, 2026.
• · Accumulated deficit widened to $476.4M from $385.9M at year-end 2025.
• · Property and equipment increased to $213.6M from $164.3M, reflecting capital investment.
• · Accounts receivable rose to $40.4M from $29.8M, while inventories jumped to $9.6M from $3.8M.
• · Total assets decreased to $1.01B from $1.05B.
• · Noncontrolling interests increased to $50.9M from $45.8M.
• · Sale of noncontrolling interest provided $19.1M in H1 2026 financing cash.
• · Proceeds from stock option exercises were $8.5M in H1 2026 vs $0.2M in H1 2025.
• · No dividends accrued on preferred stock in 2026 vs $5.3M in Q2 2025 and $11.3M in H1 2025.
• · Acquisition-related net assets: ExoTerra $93.4M, Estes $64.2M.

04-08-2026

Qnity Electronics reported Q2 FY26 net sales of $1,429M, up 22% YoY from $1,170M, driven by strong growth in both segments (Semiconductor Technologies +16%, Interconnect Solutions +30%). However, net income available to common stockholders fell 34% to $124M from $188M, and diluted EPS dropped 34% to $0.59 from $0.90, due to higher transformation charges ($42M vs $2M), new interest expense ($61M vs $0), and increased SG&A. For the six-month period, net sales rose 20% to $2,744M, but net income declined 25% to $275M.

• · Q2 FY26 gross margin was 46.6% (($1,429M - $763M)/$1,429M) vs 46.2% in Q2 FY25, a slight improvement.
• · Q2 FY26 operating cash flow was $376M for H1, down 21.7% from $480M in H1 FY25.
• · Capital expenditures in H1 FY26 were $212M, up 38.6% from $153M in H1 FY25.
• · The company paid $34M in dividends ($0.08 per share) and repurchased $50M of common stock in H1 FY26.
• · Long-term debt stood at $3,997M at June 30, 2026, essentially flat from $4,003M at year-end 2025.
• · Goodwill remained nearly unchanged at $7,518M (June 30, 2026) vs $7,522M (Dec 31, 2025).
• · Accumulated other comprehensive loss worsened to $(269)M from $(213)M, driven by negative cumulative translation adjustments.
• · The company transitioned from a Parent Company Net Investment structure to a traditional equity structure with common and preferred stock.

04-08-2026

Credit Acceptance Corp reported net income of $135.9M for Q2 2026, up 55.5% from $87.4M in Q2 2025, driven by a 0.6% increase in total revenue to $587.4M and a 10.1% decline in total operating expenses to $134.1M. However, the company's cash position weakened significantly, with cash and cash equivalents falling to $1.4M from $22.8M at year-end 2025, and total shareholders' equity declined 3.4% from $1,523.6M to $1,588.9M (note: equity actually increased to $1,588.9M from $1,523.6M, a 4.3% increase). The company continued aggressive share repurchases, buying back 262,963 shares for $141.4M in Q2 2026, while also increasing borrowings under revolving secured lines of credit.

• · Net income per diluted share rose to $12.66 in Q2 2026 from $7.42 in Q2 2025, a 70.6% increase.
• · Total provision for credit losses decreased 7.8% YoY to $159.2M in Q2 2026, driven by a 19.5% decline in provision for credit losses on forecast changes ($81.6M vs $101.3M).
• · Interest expense fell 9.1% YoY to $107.4M in Q2 2026.
• · Sales and marketing expenses increased 12.4% YoY to $29.9M in Q2 2026.
• · Other income declined 12.6% YoY to $16.6M in Q2 2026.
• · Cash and cash equivalents plummeted 93.9% from $22.8M at Dec 31, 2025 to $1.4M at June 30, 2026.
• · Total cash and cash equivalents and restricted cash and cash equivalents decreased 12.7% from $563.8M at June 30, 2025 to $492.1M at June 30, 2026.
• · Net cash provided by operating activities increased 35.1% to $656.3M in H1 2026 from $485.9M in H1 2025.
• · Net cash used in investing activities improved 25.2% to $363.5M in H1 2026 from $485.8M in H1 2025.
• · The company repurchased 628,221 shares for $320.3M in H1 2026, compared to 858,669 shares for $426.6M in H1 2025.
• · Loans receivable, net increased slightly to $7,959.2M as of June 30, 2026 from $7,909.2M at Dec 31, 2025.
• · Allowance for credit losses increased to $3,649.5M as of June 30, 2026 from $3,602.3M at Dec 31, 2025.
• · Total assets decreased marginally to $8,622.6M as of June 30, 2026 from $8,631.7M at Dec 31, 2025.
• · Secured financing decreased to $5,019.0M as of June 30, 2026 from $5,158.8M at Dec 31, 2025.
• · Revolving secured lines of credit increased to $177.8M as of June 30, 2026 from $107.3M at Dec 31, 2025.

04-08-2026

Pacira BioSciences reported net income of $4.7M for Q2 2026 and $7.6M for H1 2026, reversing net losses of $4.8M and $35K in the prior-year periods. Total revenues grew 6.3% YoY in Q2 to $192.4M and 5.6% in H1 to $369.8M, driven by net product sales. However, operating income fell sharply in Q2 to $4.3M from $8.5M, and the company continued share repurchases ($50.4M in H1) while cash and investments totaled $251.0M.

• · Assets held for sale of $67.3M were recorded at June 30, 2026, with corresponding liabilities of $0.7M, indicating a planned divestiture.
• · Goodwill decreased slightly from $20.2M to $19.6M, and intangible assets, net fell from $368.1M to $285.5M, largely due to amortization.
• · The company repurchased 2.245M treasury shares in H1 2026 for $50.4M (including excise tax and broker fees), compared to $50.0M in H1 2025.
• · Net cash provided by operating activities surged 75.1% to $83.1M in H1 2026 from $47.5M in H1 2025, driven by improved net income and working capital changes.
• · Interest income dropped sharply from $5.0M in Q2 2025 to $1.9M in Q2 2026, reflecting lower investment balances and yields.
• · Other operating expenses, net increased to $7.6M in Q2 2026 from $0.6M in Q2 2025, a significant rise.

04-08-2026

04-08-2026

04-08-2026

Crexendo, Inc. reported strong revenue growth for Q2 2026, with total revenue up 48.9% YoY to $24.6M, driven by a 77.5% surge in service revenue and a 103.7% jump in product revenue. However, net income declined 14.7% YoY to $1.05M, and operating income fell 4.4% YoY, reflecting higher operating expenses. The company also completed a business acquisition in H1 2026, spending $26.2M in cash and issuing $7.4M in stock, which contributed to a significant cash outflow and a 41.7% drop in cash and cash equivalents.

• · Operating expenses increased 52.7% YoY in Q2 2026 to $23.6M, with selling and marketing expenses up 82.3% YoY.
• · The company issued $5.0M in notes payable during H1 2026, with $147K in debt issuance costs.
• · Depreciation and amortization nearly doubled YoY in H1 2026, rising to $3.07M from $1.63M.
• · Cash flow from operations improved to $4.79M in H1 2026 from $2.53M in H1 2025.
• · The acquisition in H1 2026 included $7.43M in stock issuance, contributing to a 7.4% increase in shares outstanding.
• · Interest expense increased significantly to $62K in Q2 2026 from $6K in Q2 2025.
• · Foreign currency translation loss of $14K in H1 2026 versus a gain of $46K in H1 2025.

04-08-2026

04-08-2026

04-08-2026

Lumen Technologies reported a net loss of $201M for Q2 2026, significantly improved from a $915M loss in Q2 2025, driven by a $628M goodwill impairment in the prior year and a $31M net loss on sale of business (vs. none). Revenue declined 9.3% YoY to $2,805M from $3,092M, while operating loss narrowed to $88M from $603M. For the six-month period, net loss was $401M versus $1,116M in the prior year, with revenue down 9.1% to $5,704M. Cash from operations improved to $2,294M from $1,665M, and the company reduced long-term debt from $17,353M to $13,150M, though stockholders' deficit deepened to $(1,488)M from $(1,117)M.

• · Selling, general and administrative expenses increased 3.2% YoY to $779M in Q2 2026 from $755M in Q2 2025.
• · Depreciation and amortization declined 2.9% YoY to $668M in Q2 2026 from $688M.
• · Interest expense decreased 40.5% YoY to $201M in Q2 2026 from $338M.
• · Net gain on early retirement of debt was $6M in Q2 2026 vs. a loss of $236M in Q2 2025.
• · Capital expenditures increased 9.7% to $1,845M in H1 2026 from $1,682M in H1 2025.
• · Deferred revenue (long-term) rose to $8,178M at June 30, 2026 from $6,406M at December 31, 2025.
• · Accumulated deficit widened to $(20,102)M from $(19,701)M at year-end 2025.
• · Net intangible assets decreased to $4,040M from $4,463M at December 31, 2025.

04-08-2026

Kratos Defense & Security Solutions reported strong revenue growth for the three and six months ended June 28, 2026, with total revenues increasing 30.5% YoY to $458.8M in Q2 and 26.9% YoY to $829.8M in the first half. Net income rose to $4.4M (Q2) and $16.3M (six months), compared to $2.9M and $7.4M in the prior-year periods. However, operating income turned negative in Q2 at -$1.6M versus a profit of $3.7M a year ago, and the company's accumulated deficit remained high at $625.6M, though improved from $641.9M at year-end 2025.

• · Cash and cash equivalents surged to $1,437.6M as of June 28, 2026, up from $560.6M at December 28, 2025, largely due to equity raises totaling $1,348.4M in the first half of 2026.
• · Goodwill increased from $595.7M to $871.2M, and intangible assets rose from $53.9M to $220.8M, reflecting acquisition activity.
• · Selling, general and administrative expenses grew 45.7% YoY in Q2 ($87.3M vs $59.9M) and 36.5% in H1 ($159.6M vs $116.9M), outpacing revenue growth.
• · Research and development expenses increased 33.3% YoY in Q2 ($13.6M vs $10.2M) and 20.3% in H1 ($24.3M vs $20.2M).
• · The company issued 16.5 million shares for equity raises in H1 2026, raising $1,348.4M in additional paid-in capital.
• · Accumulated other comprehensive income swung from $2.1M (positive) at year-end 2025 to $0.6M as of June 28, 2026, due to currency translation adjustments.

04-08-2026

EOG Resources reported strong Q2 2026 results with net income of $2.724B ($5.15 diluted EPS) for the three months ended June 30, 2026, more than doubling from $1.345B ($2.46 diluted EPS) in the same period last year. Total operating revenues surged 57% to $8.620B driven by higher crude oil and condensate revenues ($4.901B vs $2.974B). However, the company saw a significant increase in operating expenses, particularly gathering, processing and transportation costs (+49%) and marketing costs (+60%), while dry hole costs nearly tripled to $30M. Net cash provided by operating activities for the first half of 2026 was $7.635B, up 77% from $4.321B in H1 2025.

• · Total assets increased to $54.783B at June 30, 2026 from $51.799B at December 31, 2025.
• · Long-term debt remained nearly flat at $7.899B (June 30, 2026) vs $7.909B (Dec 31, 2025).
• · Cash and cash equivalents rose to $4.907B from $3.396B at year-end 2025.
• · Stockholders' equity grew to $31.864B from $29.833B at December 31, 2025.
• · The company repurchased $1.712B in treasury stock during H1 2026, up from $1.402B in H1 2025.
• · Dividends declared per share decreased to $2.04 in H1 2026 from $2.97 in H1 2025.
• · Impairments decreased to $58M in H1 2026 from $83M in H1 2025.
• · Gains on asset dispositions were $89M in H1 2026 vs a loss of $1M in H1 2025.
• · Net cash used in investing activities was $3.326B in H1 2026, slightly up from $3.211B in H1 2025.
• · Net cash used in financing activities was $2.798B in H1 2026, down from $2.987B in H1 2025.

04-08-2026

Dorman Products reported Q2 FY2026 net sales of $544.6M, up 0.7% YoY from $541.0M, and net income of $87.8M, up 49.5% from $58.7M. The strong earnings growth was driven by a 14.4% increase in gross profit to $251.2M, reflecting improved gross margins. However, the Light Duty segment posted flat sales, and the Specialty Vehicle segment saw a slight decline, while Heavy Duty grew 6.8%.

• · Q2 2026 gross margin improved to 46.1% from 40.6% in Q2 2025.
• · Light Duty segment income from operations rose 33.8% to $104.7M despite flat sales, driven by lower cost of goods sold.
• · Heavy Duty segment income from operations surged to $2.8M from $0.5M in Q2 2025.
• · Specialty Vehicle segment income from operations increased 49.5% to $14.1M despite a 1% sales decline.
• · Cash and cash equivalents more than doubled to $132.0M from $49.4M at year-end 2025.
• · The company issued $450M in senior notes and repaid $440.6M of long-term debt during the first half of 2026.
• · Share repurchases totaled $97.4M in the first half of 2026, up from $15.6M a year ago.
• · Accounts receivable factoring sales declined 21% in Q2 2026 to $280.3M from $354.9M in Q2 2025.
• · Intangible assets, net decreased to $246.4M from $257.1M at year-end 2025 due to amortization.

04-08-2026

Eve Holding, Inc. reported a net loss of $34.2M for Q2 2026, significantly improved from a $64.7M loss in Q2 2025, driven by a 36.6% reduction in R&D expenses and a $2.3M gain from warrant liability remeasurement. However, operating cash flow worsened to a use of $115.3M in H1 2026 from $80.5M in H1 2025, and total equity collapsed from $123.8M at year-end 2025 to just $22.8M as accumulated deficit reached $810.1M. The company raised $178.3M in new debt during H1 2026, increasing long-term debt to $303.1M, while cash and investments fell to $394.7M from $384.1M.

• · Financial investments increased to $342.5M as of June 30, 2026 from $280.8M at December 31, 2025.
• · Warrant liability decreased to $1.7M from $4.6M, generating a $2.3M gain in Q2 2026.
• · Interest expense rose to $5.2M in Q2 2026 from $2.4M in Q2 2025, reflecting higher debt levels.
• · Capitalized software, net increased to $7.4M from $4.8M.
• · Property, plant & equipment, net grew to $13.6M from $10.6M, driven by tooling and construction in process.
• · Related party payables (current) remained high at $70.4M, essentially unchanged from year-end.
• · Cash paid for interest in H1 2026 was $6.0M, up from $4.3M in H1 2025.

04-08-2026

Palantir Technologies reported a strong Q2 2026 with revenue of $1.935B, up 92.8% YoY from $1.004B, and net income attributable to common stockholders of $1.062B, up 225% from $0.327B. For the six-month period, revenue grew 89.0% to $3.568B and net income rose 257% to $1.932B. However, the company recorded an accumulated other comprehensive loss of $(7.1M) compared to a gain of $13.9M at year-end 2025, driven by foreign currency translation and unrealized losses on securities.

• · Earnings per share (diluted) for Q2 2026 was $0.41, up from $0.13 in Q2 2025.
• · Earnings per share (diluted) for H1 2026 was $0.75, up from $0.21 in H1 2025.
• · Gross profit for Q2 2026 was $1.639B (84.7% margin) vs $0.811B (80.8% margin) in Q2 2025.
• · Total operating expenses for Q2 2026 were $726.6M, up 34.2% from $541.4M in Q2 2025.
• · Stock-based compensation for H1 2026 was $466.8M, up 48.0% from $315.3M in H1 2025.
• · The company repurchased 8 shares of common stock for $1,500 during H1 2026.
• · Net unrealized loss on available-for-sale securities was $16.8M in H1 2026 vs $2.3M in H1 2025.
• · Foreign currency translation adjustments were a loss of $4.2M in H1 2026 vs a gain of $12.7M in H1 2025.
• · Total equity increased to $9.885B as of June 30, 2026 from $7.488B as of December 31, 2025.
• · Noncontrolling interests were $110.7M as of June 30, 2026 vs $100.7M as of December 31, 2025.
• · The company held $7.195B in U.S. Treasury securities as marketable securities as of June 30, 2026.
• · Publicly-traded equity securities increased to $184.1M as of June 30, 2026 from $23.4M as of December 31, 2025.
• · Accounts receivable increased 42.5% to $1.485B, indicating potential collection risk or strong sales growth.
• · Deferred revenue (current) grew 41.7% to $579.4M, while noncurrent deferred revenue declined 27.0% to $33.7M.
• · Customer deposits (current) increased 26.6% to $452.1M.
• · Net cash provided by operating activities was $2.115B in H1 2026, up 149% from $0.850B in H1 2025.
• · Net cash used in investing activities was $1.510B in H1 2026, down 24.8% from $2.007B in H1 2025.
• · Net cash provided by financing activities was $8.4M in H1 2026 vs net cash used of $22.4M in H1 2025.
• · The company's accumulated deficit improved by 54.2% to $1.630B from $3.562B at year-end 2025.

04-08-2026

ImmunityBio reported total revenue of $95.4M for the first half of 2026, up 122% from $42.9M in the same period last year, driven by product revenue growth from ANKTIVA sales. However, the company's net loss widened dramatically to $863.2M from $222.2M, primarily due to a $332.6M fair value loss on the related-party convertible note and a $339.6M loss on warrant liabilities. Operating loss improved slightly to $131.5M from $135.7M, while operating expenses rose to $226.9M from $178.7M.

• · Company's stockholder's deficit increased to -$1.05 billion as of June 30, 2026 from -$499.6 million at December 31, 2025.
• · Warrant liabilities surged to $352.4 million from $84.4 million in just six months.
• · Accumulated deficit reached $4.59 billion as of June 30, 2026.
• · Total current assets stood at $439.0 million against current liabilities of $76.7 million.
• · Net loss per share (basic and diluted) was -$0.83 for the six months ended June 30, 2026 vs. -$0.26 a year ago.
• · Weighted-average shares outstanding increased to 1.04 billion from 870.8 million year-over-year.
• · Interest expense related to revenue interest liability was $31.1 million for the first half of 2026, up from $26.9 million.

04-08-2026

For the quarter ended June 30, 2026, net income rose 57% YoY to $390M, driven by a 5% increase in net interest income and an 18% rise in other revenues, while the provision for credit losses reversed to a benefit of $38M versus an expense of $42M a year ago. However, total interest income declined 9% YoY to $1,732M due to lower loan and short-term investment income, and total operating expenses edged up 1% to $703M. For the six-month period, net income grew 52% to $681M, but total interest income fell 10% to $3,428M and net cash used in operations was $2,733M versus $445M used in the prior period.

• · Interest income from loans fell 10% YoY to $801M in Q2 2026, and short-term investment income dropped 34% to $271M.
• · Interest expense on deposits declined 16% YoY to $771M, while total interest expense fell 15% to $1,183M.
• · Other fees and commissions grew 35% YoY to $241M, and trading revenue rose 11% to $212M.
• · Support services from HSBC affiliates increased 6% to $483M, while salaries and employee benefits decreased 12% to $141M.
• · Cash used in operating activities for H1 2026 was $2,733M, compared to $445M used in H1 2025, driven by a $3,375M net change in trading assets and liabilities.
• · Total assets grew 4.8% to $180,708M from December 31, 2025, driven by increases in trading assets and securities.
• · Common dividends declared in Q2 2026 were $300M, down 70% from $1,000M in Q2 2025.
• · Accumulated other comprehensive loss widened to $1,418M from $1,379M at year-end 2025, primarily due to unrealized losses on investment securities.

04-08-2026

Gartner Inc. reported Q2 2026 net income of $275.5M, up 14.4% from $240.8M in Q2 2025, with diluted EPS rising to $4.14 from $3.11. Total revenues declined slightly to $1.676B from $1.686B, as growth in Insights (+2.1%) and Conferences (+15.5%) was offset by a sharp drop in Consulting (-8.8%) and the elimination of the 'Other' revenue line. The company generated $789.3M in operating cash flow in H1 2026, up from $697.1M, but spent $1.08B on share repurchases, contributing to a negative stockholders' equity of ($167.3M) at quarter-end.

• · The 'Other' revenue line, which contributed $55.9M in Q2 2025, was eliminated in Q2 2026, reflecting the divestiture of a non-core operation.
• · Gain from sale of divested operation was $739K in Q2 2026 and $5.4M for H1 2026.
• · Interest expense, net increased to $22.3M in Q2 2026 from $11.8M in Q2 2025, an 88.7% rise.
• · Total liabilities decreased to $7.361B from $7.765B at year-end 2025, primarily due to lower accounts payable and accrued liabilities.
• · The company's stockholders' equity turned negative to ($167.3M) from positive $319.9M at year-end 2025, driven by $1.08B in share repurchases.
• · Deferred revenues decreased to $2.756B from $2.810B at year-end 2025.
• · Fees receivable, net declined to $1.202B from $1.685B at year-end 2025, a 28.6% drop.
• · Cash used in financing activities was $1.073B in H1 2026 vs. $419.7M in H1 2025, mainly due to increased share repurchases.

04-08-2026

Lipocine Inc. reported a net loss of $2.62M for Q2 2026, wider than the $2.21M loss in Q2 2025, driven by a 69% drop in total revenue to $0.19M due to the absence of license revenue. While royalty revenue grew 55% to $0.19M, operating expenses remained flat at $3.03M, and the company raised $13.47M net through an ATM offering, boosting cash reserves. However, cash used in operations increased to $5.29M for the first half of 2026, and the accumulated deficit grew to $215.69M.

• · Cash and cash equivalents decreased to $4.98M at June 30, 2026 from $5.21M at December 31, 2025.
• · The company had $18.29M in government treasury bills at fair value at June 30, 2026.
• · Stock-based compensation expense was $123,543 for H1 2026, down from $136,207 in H1 2025.
• · The company sold 2,083,276 shares through its ATM offering in H1 2026, raising $13.47M net.
• · Accumulated deficit increased to $215.69M at June 30, 2026 from $209.40M at December 31, 2025.

04-08-2026

Atkore Inc. reported a net loss of $108.3M for the nine months ended June 26, 2026, compared to net income of $39.2M in the prior-year period, driven by a $186.5M litigation settlement expense and a $35.9M other expense. While net sales grew 4.0% to $2.18B, gross profit declined 17.0% to $438.3M, and operating income improved to $94.4M from $79.9M, but only after significant asset impairment charges in the prior year. Cash flow from operations turned negative at -$90.3M, a sharp reversal from $192.4M a year ago.

• · Asset impairment charges were $11.6M in the current nine-month period vs. $127.7M in the prior year.
• · The company recorded a $50.0M accrued settlement liability as of June 26, 2026.
• · Capital expenditures decreased to $40.4M from $84.9M in the prior-year nine-month period.
• · The company repurchased $0 of common stock in the current nine-month period vs. $100.0M in the prior year.
• · Dividends paid were $33.4M, roughly flat vs. $33.1M a year ago.
• · Equity method investment of $54.0M was recorded as of June 26, 2026, up from $0 at September 30, 2025.
• · Accounts receivable increased $163.4M (cash flow impact) vs. $64.5M in the prior year, a significant use of cash.

04-08-2026

Ares Commercial Real Estate Corp (ACRE) reported a net loss of $5.2M for the six months ended June 30, 2026, compared to a $1.7M net loss in the prior year period. However, the company posted a net income of $4.4M in Q2 2026, a significant improvement from a net loss of $11.0M in Q2 2025. Total revenue increased 14% YoY to $14.4M in Q2 2026, driven by higher net interest margin and real estate owned revenue, but the company recorded a $12.0M provision for credit losses in H1 2026 versus a $25.5M reversal in H1 2025, and total assets grew 12% to $1.82B.

• · Interest income for Q2 2026 was $27,754, up 20.1% from $23,117 in Q2 2025.
• · Interest expense for Q2 2026 was $19,182, up 19.1% from $16,101 in Q2 2025.
• · Revenue from real estate owned for Q2 2026 was $5,784, up 4.2% from $5,549 in Q2 2025.
• · Management and incentive fees to affiliate for Q2 2026 were $2,394, down 1.5% from $2,430 in Q2 2025.
• · Expenses from real estate owned for Q2 2026 were $3,301, down 28.7% from $4,628 in Q2 2025.
• · Weighted average basic shares outstanding for Q2 2026 were 55,367,375, up 0.9% from 54,856,949 in Q2 2025.
• · Dividends declared per share remained flat at $0.15 per quarter.
• · Net cash provided by operating activities for H1 2026 was $6,938, down 46.2% from $12,890 in H1 2025.
• · Net cash used in investing activities for H1 2026 was $211,278, compared to $324,998 provided in H1 2025.
• · Net cash provided by financing activities for H1 2026 was $195,758, compared to $310,047 used in H1 2025.
• · Weighted average unleveraged effective yield on senior mortgage loans was 5.8% as of June 30, 2026.
• · Weighted average remaining life of total loans held for investment was 1.4 years as of June 30, 2026.
• · Total loans held for investment portfolio outstanding principal was $1,840,169 as of June 30, 2026.

04-08-2026

TETRA Technologies reported mixed results for Q2 and H1 2026. While total revenues grew 6.8% YoY in Q2 to $185.7M and net income for H1 increased 20.9% to $18.6M, Q2 net income fell 9.4% YoY to $10.2M and gross profit declined 5.2% in Q2. The company completed a public offering raising $108.4M net, strengthening its balance sheet with cash more than doubling to $154.6M, but operating cash flow dropped sharply to $22.5M in H1 from $52.3M a year ago.

• · Product sales revenue was essentially flat in Q2 2026 at $103.6M vs $102.7M in Q2 2025, and declined 2.1% in H1 to $186.9M from $190.9M.
• · Services revenue grew 15.3% YoY in Q2 to $82.1M and 10.6% in H1 to $155.0M.
• · Cost of product sales increased 20.6% in Q2 to $69.2M, significantly outpacing product sales growth.
• · Interest expense decreased 22.1% in Q2 to $3.3M and 27.1% in H1 to $6.5M.
• · Income tax expense fell 30.9% in Q2 to $5.6M, contributing to the lower net income decline relative to pre-tax income.
• · Total equity increased 43.9% from $282.5M at Dec 31, 2025 to $406.5M at June 30, 2026, primarily due to the public offering.
• · Capital expenditures (PP&E purchases) increased 13.1% to $42.3M in H1 2026 from $37.4M in H1 2025.
• · The company had a retained deficit of $146.9M at June 30, 2026, improved from $165.4M at Dec 31, 2025.

04-08-2026

Public Co Management Corp (PCMC) reported no revenues for the three and nine months ended June 30, 2026, and continued to incur losses. Operating loss increased 5.7% to $24,560 in Q3 FY26 from $23,239 in Q3 FY25, while the nine-month operating loss nearly doubled to $117,498 from $59,481. Cash decreased sharply from $234,405 to $6,692, and the company's accumulated deficit deepened to $5,851,867, highlighting a deteriorating liquidity position and lack of revenue generation.

• · The company had no revenue in both the three- and nine-month periods ended June 30, 2026 and 2025.
• · Total assets were only $6,692 as of June 30, 2026, down 97.5% from $267,642 at September 30, 2025.
• · Total current liabilities of $329,543 exceed total assets by a wide margin, resulting in a working capital deficit of ~$322,851.
• · Related-party payables increased from $4,799 to $18,499, and note payable – related party is $279,484.
• · A $130,000 note receivable from a related party was issued during 9M FY26, but was partially offset ($168,545) against the related party note payable in a non-cash transaction.
• · The company restated its 9M FY25 results, increasing general and administrative expenses by $6,000 (from ($65,481) to ($59,481)) and decreasing net loss by $6,000 (from ($7,356) to ($67,356)).

04-08-2026

Snap Inc reported Q2 2026 revenue of $1,598,993 thousand, up 18.9% YoY from $1,344,930 thousand, driven by strong growth in Other revenue (+84.7% to $316,471 thousand) while Advertising revenue grew 9.3% to $1,282,522 thousand. Net loss narrowed to $163,960 thousand from $262,570 thousand in Q2 2025, a 37.6% improvement, and operating cash flow more than doubled to $176,214 thousand. However, the company still posted a net loss and total costs rose 10.3% YoY, with R&D expenses up 22.3%.

• · Q2 2026 basic and diluted net loss per share improved to $(0.10) from $(0.16) in Q2 2025.
• · H1 2026 basic and diluted net loss per share improved to $(0.15) from $(0.24) in H1 2025.
• · Q2 2026 stock-based compensation expense was $263,189 thousand, up 4.5% YoY from $251,886 thousand.
• · Q2 2026 cash used for repurchases of Class A non-voting common stock was $250,465 thousand, up from $243,473 thousand in Q2 2025.
• · H1 2026 cash used for repurchases of Class A non-voting common stock was $600,964 thousand, up from $500,573 thousand in H1 2025.
• · Total stockholders' equity decreased to $1,927,088 thousand at June 30, 2026 from $2,281,495 thousand at December 31, 2025, a 15.5% decline.
• · Accumulated deficit widened to $14,800,691 thousand at June 30, 2026 from $13,946,816 thousand at December 31, 2025.
• · Cash, cash equivalents, and restricted cash decreased to $960,491 thousand at June 30, 2026 from $1,031,397 thousand at December 31, 2025.
• · Q2 2026 interest expense increased to $36,941 thousand from $27,607 thousand in Q2 2025, a 33.8% rise.
• · Q2 2026 interest income decreased to $24,672 thousand from $33,199 thousand in Q2 2025, a 25.7% decline.

04-08-2026

Paymentus Holdings reported strong Q2 2026 results with revenue of $360.7M, up 28.8% YoY from $280.1M, and net income of $25.6M, up 73.8% from $14.7M. For the six-month period, revenue grew 29.5% to $719.2M and net income rose 62.8% to $46.4M. However, operating cash flow declined slightly to $79.3M from $81.9M in the prior-year period, and the company's accumulated other comprehensive loss widened to $(0.6M) from $(0.4M).

• · Payment transaction processing revenue was $357.8M in Q2 2026 vs $278.1M in Q2 2025, up 28.7%.
• · Other revenue was $2.9M in Q2 2026 vs $2.0M in Q2 2025.
• · Gross profit margin improved to 26.1% in Q2 2026 from 25.5% in Q2 2025.
• · Operating expenses increased 11.0% in Q2 2026 to $61.7M from $55.6M, driven by sales & marketing (+11.6%) and G&A (+24.4%).
• · Provision for income taxes more than doubled to $10.1M in Q2 2026 from $3.7M in Q2 2025.
• · Capitalized internal-use software development costs increased to $72.8M at June 30, 2026 from $70.9M at Dec 31, 2025.
• · Goodwill remained nearly flat at $131.8M.
• · Accumulated other comprehensive loss worsened to $(0.6M) from $(0.4M) due to foreign currency translation.
• · Cash paid for income taxes, net of refunds, was $20.3M in H1 2026 vs $10.3M in H1 2025.

04-08-2026

Tennessee Valley Authority (TVC) reported net income of $307M for Q3 FY2026 (quarter ended June 30, 2026), up 44.8% from $212M in the same quarter last year, driven by higher operating revenues and lower depreciation. For the nine-month period, net income rose 29.5% to $965M from $745M. However, operating cash flow declined 9.3% to $1,883M for the nine months, and total operating expenses increased slightly, with fuel costs rising 16.3% in the quarter.

• · Total assets increased 1.3% to $61.644B from $60.882B.
• · Total liabilities decreased slightly to $42.161B from $42.371B.
• · Proprietary capital increased 5.3% to $19.483B from $18.511B.
• · Construction in progress rose 19.4% to $8.073B from $6.760B.
• · Investment funds increased 12.1% to $6.245B from $5.573B.
• · Accounts payable and accrued liabilities decreased 4.6% to $3.148B from $3.299B.
• · Current maturities of power bonds decreased 25.5% to $1.020B from $1.370B.
• · Asset retirement obligations (long-term) decreased 8.7% to $9.222B from $10.101B.
• · Post-retirement benefit obligations decreased 9.0% to $1.987B from $2.183B.
• · Operating and maintenance expenses for the nine months decreased 2.7% to $2.695B from $2.771B.
• · Purchased power expense increased 2.4% in Q3 and 3.0% for the nine months.
• · Construction expenditures decreased 17.0% to $2.874B for the nine months.
• · Proceeds from variable interest entities were $2.000B in the nine months, up from $800M.
• · Redemptions and repurchases of power bonds were $1.370B, up from $1.022B.

04-08-2026

Matson, Inc. reported strong Q2 2026 results with total operating revenue of $969.4M, up 16.7% from $830.5M in Q2 2025, driven by growth in both Ocean Transportation (+13.6% to $767.4M) and Logistics (+30.4% to $202.0M). Net income rose 36.6% to $129.4M from $94.7M, and diluted EPS increased to $4.27 from $2.92. However, income from SSAT declined 34.2% to $4.8M, and the company continued aggressive share repurchases ($119.8M in H1 2026), reducing basic shares outstanding from 32.1M to 30.1M year-over-year.

• · Total operating revenue for H1 2026 was $1,727.2M, up 7.1% from $1,612.5M in H1 2025.
• · Operating income for Q2 2026 was $158.9M, up 40.6% from $113.0M in Q2 2025.
• · Cash flow from operations for H1 2026 was $231.6M, up 19.0% from $194.6M in H1 2025.
• · Vessel construction expenditures in H1 2026 were $199.8M, nearly double the $104.1M in H1 2025.
• · Capital Construction Fund balance decreased to $345.8M at June 30, 2026 from $532.7M at December 31, 2025.
• · Dividends paid in H1 2026 were $22.0M, slightly down from $22.3M in H1 2025.
• · Total shareholders' equity increased to $2,773.1M at June 30, 2026 from $2,759.0M at December 31, 2025.
• · Long-term debt, net of deferred loan fees, decreased to $292.7M from $312.1M at year-end 2025.

04-08-2026

Rhythm Pharmaceuticals reported strong product revenue growth of 47% YoY to $71.3M in Q2 2026 and 52% YoY to $131.4M in H1 2026, driven by increased sales of its obesity drug. However, the company's net loss widened to $49.3M in Q2 (from $46.6M a year ago) and to $104.9M in H1 (from $96.1M), as selling, general, and administrative expenses surged 47% to $67.4M in the quarter. Total assets declined 9% to $437.3M, while cash and investments fell to $330.9M from $388.9M at year-end 2025, reflecting ongoing cash burn.

• · Inventory increased 18.5% to $30.5M from $25.8M, with finished goods rising to $19.6M from $17.4M.
• · Accounts receivable grew 55% to $40.4M from $26.1M, indicating potential collection risk.
• · Deferred royalty obligation (current) rose 74% to $12.7M from $7.3M, while long-term portion decreased to $93.4M from $100.9M.
• · Accrued expenses and other current liabilities increased 12% to $94.0M, driven by a 35% jump in sales allowances to $42.8M.
• · Series A preferred stock was reduced by 17,500 shares during H1 2026 via conversion to common stock, lowering the liquidation preference to $116.5M.
• · Net cash provided by investing activities was $71.1M in H1 2026, down from $78.8M in H1 2025, as maturities exceeded purchases.
• · Financing activities used $6.6M in H1 2026 versus providing $31.6M in H1 2025, due to the absence of an ATM offering and higher royalty repayments.
• · The company held $49.1M in money market funds and $265.3M in marketable securities (US treasuries and corporate debt) at June 30, 2026.
• · Accumulated deficit grew to $1.46B from $1.35B at year-end 2025.
• · Weighted-average diluted shares outstanding increased to 68.6M in Q2 2026 from 63.7M in Q2 2025.

04-08-2026

Hut 8 Corp. reported a net loss of $150.2M for Q2 2026, a sharp reversal from net income of $137.3M in Q2 2025, driven by a $138.6M loss on digital assets versus a $217.6M gain a year ago. Total revenue more than doubled to $74.9M (+81% YoY), led by Compute revenue surging to $72.5M (+111% YoY). However, Power revenue fell 79% to $1.2M and Digital Infrastructure revenue declined 15% to $1.3M. Total assets ballooned to $9.98B from $2.75B at year-end 2025, primarily due to $7.7B in new debt financing, while the company swung to an operating loss of $206.3M from a $187.9M operating profit in the prior-year quarter.

• · The company raised $7.7B in new debt financing during H1 2026, contributing to a $6.97B net increase in cash and restricted cash.
• · Restricted cash and cash equivalents surged to $6.79B as of June 30, 2026, from just $2.4M at year-end 2025.
• · Non-current loans, notes payable, and other financial liabilities jumped to $7.40B from $210.2M at December 31, 2025.
• · Interest expense increased 509% YoY to $51.2M in Q2 2026, while interest income was $27.1M (nil in Q2 2025).
• · The company recorded a $34.7M gain on sale of the Far North JV in H1 2026.
• · Digital assets held in custody declined 14.3% to $567.3M, and digital assets pledged as collateral fell 26.8% to $290.3M.
• · Stock-based compensation surged to $102.1M in H1 2026 from $11.4M in H1 2025.
• · The company issued 9.7M shares upon convertible note conversion in Q2 2026.
• · American Bitcoin Corp. raised $144.1M via an ATM offering and $33.6M in non-ATM Class A common stock issuance in H1 2026.
• · Property and equipment more than doubled to $1.37B, driven by $616.2M in capital expenditures.
• · The accumulated deficit reached $364.6M as of June 30, 2026, compared to retained earnings of $5.5M at year-end 2025.
• · Deferred tax liabilities decreased 58.8% to $53.5M, while the company recorded an $80.4M income tax benefit in H1 2026.
• · Goodwill decreased slightly by 1.0% to $208.0M.
• · Investment in unconsolidated joint venture decreased 12.4% to $39.6M.
• · The company purchased $65.3M in Bitcoin during H1 2026.

04-08-2026

PSQ Holdings, Inc. reported a net loss of $12.1M for the six months ended June 30, 2026, improving from a $12.8M loss in the prior-year period. Revenue more than doubled to $15.3M (up 136% YoY), driven by strong growth in loans and leases. However, operating expenses also rose sharply, and the company's cash position declined significantly from $16.1M to $8.3M, while stockholders' equity fell from $13.4M to $4.2M.

• · Revenue for Q2 2026 was $7.1M, up from $3.4M in Q2 2025 (108% YoY increase).
• · Operating loss for Q2 2026 was $4.8M, improving from $5.2M in Q2 2025.
• · Net loss from discontinued operations was $0.4M for six months ended June 30, 2026, down from $5.3M in the prior period.
• · Share-based compensation was $2.6M for six months ended June 30, 2026, down from $3.6M in the prior period.
• · Net cash used in operating activities improved to $6.5M from $11.3M in the prior period.
• · Proceeds from sale of loans and leases for resale were $29.7M for six months ended June 30, 2026, up from $16.4M in the prior period.
• · Gain on sale of loans and leases was $4.2M for six months ended June 30, 2026, up from $1.6M in the prior period.
• · The company executed a reverse stock split, reducing Class A shares outstanding from 48.7M to 3.2M as of March 31, 2026.
• · All Class C Common Stock was converted to Class A or cancelled during the period.
• · Convertible promissory notes (related party and other) totaled $28.4M as of June 30, 2026, unchanged from December 31, 2025.
• · Warrant liabilities decreased from $1.2M to $0.5M due to fair value changes.
• · Earn-out liabilities decreased from $0.5M to $21,000 due to fair value changes.

04-08-2026

ACRES Commercial Realty Corp. reported a net loss allocable to common shares of $12.5M for Q2 2026, a significant deterioration from a $0.7M loss in Q2 2025, driven by $5.1M in merger and internalization costs and a $1.7M provision for credit losses. While net interest income grew 22.8% YoY to $10.5M, total revenues declined 4.1% as real estate income fell 21.4%, with rental income dropping 63.2%. The company's CRE loan portfolio expanded 16.3% to $2.13B, funded by a $879.5M securitization, but cash and cash equivalents nearly halved to $41.1M.

• · Net loss per common share (basic and diluted) was $(1.87) for Q2 2026 vs $(0.10) for Q2 2025.
• · Net loss per common share (basic and diluted) was $(2.04) for H1 2026 vs $(0.90) for H1 2025.
• · Weighted average common shares outstanding (basic) decreased to 6,693,915 in Q2 2026 from 7,250,624 in Q2 2025.
• · Total assets grew to $2.41B as of June 30, 2026 from $2.16B as of Dec 31, 2025.
• · Borrowings, net increased to $1.78B from $1.54B over the same period.
• · Equity compensation expense (related party) surged to $4.9M in Q2 2026 from $0.6M in Q2 2025.
• · The company consolidated $1.01B in VIE assets and $875.3M in VIE liabilities as of June 30, 2026, which were not present at Dec 31, 2025.
• · Net cash used in investing activities was $276.6M in H1 2026 vs net cash provided of $54.6M in H1 2025.
• · Net cash provided by financing activities was $226.2M in H1 2026 vs net cash used of $74.6M in H1 2025.
• · Distributions paid on preferred stock totaled $10.2M in H1 2026.

04-08-2026

Vivid Seats Inc. reported a net loss of $14.3M for Q2 2026, a significant improvement from the $263.3M loss in Q2 2025, which included a $320.4M impairment charge. However, revenues declined 9.5% YoY to $129.9M, driven by a 9.2% drop in Marketplace revenues and a 40.0% decline in Private Label Offering revenues. The company generated $45.2M in operating cash flow in H1 2026 versus a $53.9M use in H1 2025, but total shareholders' deficit widened to $105.1M from $85.1M at year-end 2025.

• · Q2 2026 net loss per share (basic) was $1.30, compared to $21.40 in Q2 2025.
• · H1 2026 net loss per share (basic) was $2.65, compared to $22.11 in H1 2025.
• · Marketing and selling expenses decreased 1.9% YoY to $52.8M in Q2 2026.
• · General and administrative expenses decreased 29.6% YoY to $32.6M in Q2 2026.
• · No impairment charges were recorded in Q2 2026 or H1 2026, versus $320.4M in the prior-year periods.
• · Accounts receivable increased 46.9% to $45.0M at June 30, 2026 from $30.7M at December 31, 2025.
• · Accounts payable increased 50.5% to $230.8M at June 30, 2026 from $153.4M at December 31, 2025.
• · Deferred revenue decreased 13.2% to $17.3M at June 30, 2026 from $20.0M at December 31, 2025.
• · Long-term debt (net) was $381.8M at June 30, 2026, down slightly from $383.4M at December 31, 2025.
• · Accumulated deficit increased to $1,388.4M at June 30, 2026 from $1,359.5M at December 31, 2025.

04-08-2026

Blackstone Digital Infrastructure Trust Inc. filed its first 10-Q for the period ended June 30, 2026, reporting zero revenue and net income of $7,080 for both the three and six months ended June 30, 2026. The company completed an IPO on May 15, 2026, raising $2.0 billion in gross proceeds from the issuance of 100.6 million shares, resulting in $1.94 billion in cash and cash equivalents at period end. However, the trust has not yet generated any revenue and reported general and administrative expenses of $1,433, reflecting its early-stage operations.

• · The company had zero revenue for both the three and six months ended June 30, 2026.
• · Net income per share (basic and diluted) was $0.14 for the three months and $0.28 for the six months ended June 30, 2026.
• · FFO per adjusted share (basic and diluted) was $0.07 for both periods; AFFO per adjusted share was $0.08 for both periods.
• · Total assets of $1,959,153 consisted almost entirely of cash and cash equivalents ($1,943,383) and other assets ($15,770).
• · The company had no prior period comparative data as it was formed in 2026.
• · Stock-based compensation was $76 for the six months ended June 30, 2026.
• · Deferred financing costs of $10,466 were paid during the period.

04-08-2026

Pfizer's Q2 2026 (three months ended June 28, 2026) total revenues rose 2.6% YoY to $15,034M, driven by growth in alliance revenues (+18.7%) and royalty revenues (+11.3%), which partially offset a slight decline in product revenues (-0.8%). However, the company reported a net loss attributable to common shareholders of $248M in Q2 2026 versus a net income of $2,910M in Q2 2025, swinging to a loss largely due to a $3,716M charge in other deductions partly reflecting asset write-offs and impairments ($4,425M in H1 2026 vs $498M in H1 2025). For the six months ended June 28, 2026, net income fell 58.5% to $2,440M from $5,877M in the prior year period.

• · Total assets decreased to $201,131M as of June 28, 2026, from $208,160M at December 31, 2025.
• · Total equity declined to $85,492M from $86,775M over the same period.
• · Long-term debt stood at $60,495M, slightly down from $61,641M at year-end 2025.
• · Cash and cash equivalents fell to $976M from $1,142M at December 31, 2025.
• · The company reported a net gain of $1,870M from the sale of its investment in ViiV during H1 2026.
• · Share repurchases were negligible; treasury stock remained nearly flat at 3,942 million shares.
• · Dividends declared were $0.86 per share in both Q2 2026 and Q2 2025.

04-08-2026

First Watch Restaurant Group reported mixed Q2 FY26 results. Total revenues grew 15.2% YoY to $354.7M for the 13 weeks ended June 28, 2026, driven by a 15.2% increase in restaurant sales and a 9.9% increase in franchise revenues. However, net income for the 26-week period swung to a loss of $0.3M from a profit of $1.3M in the prior year, and the company reported a net loss for the first quarter of FY26. Operating cash flow improved slightly to $61.9M for the 26 weeks, but capital expenditures remained high at $69.8M.

• · Interest expense increased 22.2% YoY to $4.9M for Q2 2026 (13 weeks).
• · General and administrative expenses rose 16.7% YoY to $38.7M for Q2 2026 (13 weeks).
• · Pre-opening expenses decreased 5.5% YoY to $3.3M for Q2 2026 (13 weeks).
• · The company acquired 19 restaurants in April 2025 for a total cash purchase price of $56.2M.
• · Goodwill from acquisitions totaled $21.6M.
• · Total equity increased to $634.2M at June 28, 2026 from $626.3M at December 28, 2025.
• · Accumulated deficit improved to ($34.7M) from ($37.1M) during Q2 2026.
• · Net cash used in investing activities was $70.5M for 26 weeks ended June 28, 2026, down from $132.8M in the prior year period.
• · Proceeds from borrowings on revolving credit facility were $386M for 26 weeks ended June 28, 2026, up from $127M in the prior year period.

04-08-2026

Pediatrix Medical Group reported Q2 2026 net revenue of $487.8M, up 4.0% YoY, and net income of $39.8M, up 1.5% YoY. However, operating income declined 4.9% YoY due to higher transformational and restructuring expenses, and cash flow from operations turned negative at -$4.5M for the six months, driven by a large decrease in accounts payable and accrued expenses. The company also increased share repurchases significantly, spending $64.2M in H1 2026 versus $1.8M in H1 2025.

• · Q2 2026 diluted EPS was $0.49, up from $0.46 in Q2 2025.
• · H1 2026 net revenue grew 4.0% YoY to $964.0M, but net income grew 15.7% YoY to $69.4M.
• · H1 2026 operating income increased 7.2% YoY to $98.6M, despite higher transformational expenses.
• · Cash and cash equivalents fell 23% from $375.2M at Dec 31, 2025 to $288.9M at June 30, 2026.
• · Total debt (current and long-term) decreased from $597.3M to $584.2M during H1 2026.
• · The company completed an acquisition in H1 2026, adding $7.5M in goodwill.
• · Share repurchases in H1 2026 totaled $64.2M, a significant increase from $1.8M in H1 2025.
• · Accounts payable and accrued expenses decreased by $117.7M in H1 2026, contributing to negative operating cash flow.
• · Retained deficit improved from -$83.2M to -$13.7M during H1 2026.
• · Total comprehensive income for Q2 2026 was $39.4M, slightly down from $39.7M in Q2 2025.

04-08-2026

Certara, Inc. reported a net loss of $55.3M for Q2 2026 and $64.0M for H1 2026, compared to a net loss of $2.0M and net income of $2.8M in the prior-year periods, driven by a $49.2M loss from discontinued operations in Q2 and a $46.1M loss for H1. Revenue grew modestly 1.0% YoY to $93.3M in Q2 and 1.6% to $187.4M in H1, but operating income swung to a loss of $0.2M (Q2) and $6.5M (H1) from profits of $7.7M and $12.0M a year ago, as operating expenses rose sharply, particularly G&A (+31.3% in Q2, +41.4% in H1). The company also repurchased $57.4M of common stock during H1 2026.

• · Goodwill decreased from $745.1M at Dec 31, 2025 to $718.1M at June 30, 2026.
• · Intangible assets, net, decreased from $361.8M to $345.2M over the same period.
• · Deferred revenue (current) increased slightly from $75.4M to $77.3M.
• · Total assets declined from $1,556.6M to $1,399.8M, primarily due to the classification of discontinued operations.
• · Cash paid for taxes in H1 2026 was $12.1M, up from $6.0M in H1 2025.
• · Equity-based compensation expense was $13.4M in H1 2026, down from $15.3M in H1 2025.
• · The company had $103.7M in money market funds (Level 1) as of June 30, 2026, up from $82.5M at Dec 31, 2025.
• · Contingent liabilities were zero at June 30, 2026, down from $21.5M at Dec 31, 2025.
• · Interest rate swap asset of $1.9M (Level 2) at June 30, 2026; liability of $2.3M (Level 2) at Dec 31, 2025.

04-08-2026

RYTHM, Inc. (RYM) reported a dramatic turnaround for Q2 FY2026, with revenue surging to $23.0M from $2.0M in Q2 FY2025, driven by a 1,027% increase. The company swung to a net income of $1.2M from a net loss of $7.4M in the prior-year quarter, and generated $9.7M in operating cash flow versus a $15.1M use of cash. However, the improvement was heavily supported by a $26.8M non-cash tax benefit from the release of a valuation allowance, and selling, general and administrative expenses more than doubled to $16.6M, signaling rising operational costs.

• · Revenue growth was driven by a 1,027% YoY increase in Q2 2026 to $23.0M, but the company's operating income from continuing operations was only $1.9M, indicating high operating costs.
• · Selling, general and administrative expenses more than doubled to $16.6M in Q2 2026 from $7.5M in Q2 2025, outpacing revenue growth.
• · Interest expense surged 493% YoY to $1.7M in Q2 2026, driven by a $1.8M related party interest component.
• · The company's net income of $1.2M in Q2 2026 was supported by a $1.2M income tax benefit, while the H1 2026 net income of $21.1M included a $26.8M non-cash tax benefit from the release of a valuation allowance.
• · Total current liabilities more than doubled to $95.5M from $43.0M at year-end 2025, driven by a $45M increase in related party debt, current.
• · The company's accumulated deficit improved to $(319.7M) from $(340.8M) at year-end 2025.
• · Cash flow from operations turned positive to $9.7M in H1 2026 from a $(15.1M) use in H1 2025.
• · The company had no investing or financing cash flows in H1 2026, compared to $5.1M used in investing and $30.0M provided by financing in H1 2025.
• · Accounts receivable decreased 15% to $7.9M, and inventory decreased 32% to $2.7M from year-end 2025.

04-08-2026

Beam Therapeutics reported a net loss of $122.7M for Q2 2026, widening from a $102.1M loss in Q2 2025, driven by a sharp decline in license and collaboration revenue ($0.5M vs $8.5M) and higher general and administrative expenses. For the first half of 2026, the net loss was $217.0M compared to $210.5M in the prior year period. The company ended the quarter with $1.15B in cash, cash equivalents, and marketable securities, down from $1.25B at year-end 2025, and took on $93.9M in new debt during the period.

• · Cash used in operating activities for H1 2026 was $194.6M, up from $180.3M in H1 2025.
• · The company issued $93.9M in debt (net of fees) during H1 2026, a new debt facility.
• · Accumulated deficit grew to $1.86B as of June 30, 2026 from $1.64B at year-end 2025.
• · Stock-based compensation expense decreased to $38.3M in H1 2026 from $51.0M in H1 2025.
• · Deferred revenue fell to zero at June 30, 2026 from $6.7M at December 31, 2025, reflecting revenue recognition.
• · The company had no preferred stock issued or outstanding.

04-08-2026

Larimar Therapeutics reported a net loss of $32.8M for Q2 2026, up 25% from $26.2M in Q2 2025, and a six-month net loss of $62.4M, up 12.5% from $55.5M. Operating expenses increased 24% in Q2 and 11% in H1, driven by higher R&D and G&A costs. The company strengthened its balance sheet with a $107.6M equity raise, ending the quarter with $156.7M in cash and marketable securities, up from $136.9M at year-end 2025. However, cash used in operations increased significantly to $88.6M in H1 2026 from $45.9M in H1 2025.

• · R&D expenses increased to $28.0M in Q2 2026 from $23.4M in Q2 2025 (up 19.8%), and to $53.0M in H1 2026 from $49.9M in H1 2025 (up 6.2%).
• · G&A expenses increased to $6.4M in Q2 2026 from $4.4M in Q2 2025 (up 43.6%), and to $12.4M in H1 2026 from $9.1M in H1 2025 (up 37.3%).
• · Nomlabofusp support costs increased to $2.1M in Q2 2026 from $1.2M in Q2 2025 (up 74.6%), and to $3.8M in H1 2026 from $2.9M in H1 2025 (up 31.1%).
• · Commercial expenses increased to $1.2M in Q2 2026 from $0.8M in Q2 2025 (up 58.0%), and to $2.3M in H1 2026 from $1.3M in H1 2025 (up 84.3%).
• · The company issued 23,000,000 shares of common stock in H1 2026, raising $107.6M in net proceeds.
• · The company issued 250,000 shares of preferred stock in exchange for 2,500,000 shares of common stock during Q1 2026.
• · Accumulated deficit increased to $497.2M as of June 30, 2026 from $434.8M at December 31, 2025.
• · Total stockholders' equity increased to $127.4M as of June 30, 2026 from $78.1M at December 31, 2025.
• · The company had $151.2M in cash equivalents and marketable securities as of June 30, 2026, all classified as Level 1 or Level 2.
• · Net loss per share (basic and diluted) for common stock was $0.30 for Q2 2026 compared to $0.41 for Q2 2025, and $0.61 for H1 2026 compared to $0.87 for H1 2025.

04-08-2026

Thryv Holdings reported a net loss of $16.7M in Q2 2026, a sharp reversal from net income of $13.9M in Q2 2025, with revenue declining 28.4% YoY to $150.7M. For the first half of 2026, revenue fell 18.7% to $318.4M and net loss widened to $12.1M from a $4.3M profit. Operating income swung to a loss of $1.1M in Q2, while cash flow from operations improved to $27.4M in H1 2026 from $19.1M in H1 2025.

• · Q2 2026 gross profit declined to $94.6M from $146.6M in Q2 2025, a 35.5% decrease.
• · Q2 2026 operating loss was $1.1M versus operating income of $29.5M in Q2 2025.
• · Q2 2026 diluted EPS was -$0.38 versus $0.31 in Q2 2025.
• · H1 2026 operating income was $2.9M versus $26.5M in H1 2025, a decline of 89.0%.
• · H1 2026 diluted EPS was -$0.27 versus $0.10 in H1 2025.
• · Total assets decreased to $654.1M at June 30, 2026 from $688.6M at December 31, 2025.
• · Total stockholders' equity decreased to $211.6M from $218.1M at year-end 2025.
• · Cash and cash equivalents decreased to $9.1M from $10.8M at December 31, 2025.
• · H1 2026 cash paid for interest was $13.4M, down from $16.5M in H1 2025.
• · H1 2026 cash received for income taxes was $4.0M versus cash paid of $3.4M in H1 2025.

04-08-2026

Hillman Solutions Corp. reported net sales of $442.3M for Q2 2026 (13 weeks ended June 27), up 9.8% YoY from $402.8M, and net income of $21.1M vs $15.8M in the prior-year quarter, a 33.4% increase. For the first half (26 weeks), net sales grew 6.6% to $812.3M, but income from operations fell 6.2% to $48.1M, and comprehensive income decreased 24.8% to $14.3M, dragged by negative foreign currency translation ($-3.3M) and a net loss of $4.7M in Q1. The company completed an acquisition for $2.6M in net cash and repurchased $23.4M of common stock during the period.

• · Cash provided by operations increased 42.5% to $68.5M (H1 2026) from $48.1M (H1 2025), driven by a $41.8M inventory reduction vs a $20.8M increase in the prior year.
• · Long-term debt increased to $678.1M as of June 27, 2026 from $668.3M at year-end 2025.
• · Accounts receivable grew 34.6% to $154.7M from $114.9M, while accounts payable decreased 7.2% to $131.5M.
• · The company acquired a business for $2.6M cash (net of $7.2M paid, $4.7M gain on acquisition).
• · During Q2 2026, $13.3M of stock was repurchased ($10.1M in Q1).

04-08-2026

Shoals Technologies Group reported strong revenue growth of 47.4% YoY to $163.4M in Q2 2026, driven by robust demand. However, net income declined 12.4% YoY to $12.1M in Q2, and operating cash flow turned sharply negative at -$34.6M for the first half of 2026, compared to positive $1.7M in the prior year period, due to a massive $97.1M inventory build.

• · Gross margin improved to 30.3% in Q2 2026 from 37.2% in Q2 2025, a decline of 690 bps.
• · Operating cash flow was negative $34.6M in H1 2026 vs positive $1.7M in H1 2025, driven largely by a $97.1M increase in inventory.
• · Inventory more than doubled to $184.7M at June 30, 2026 from $89.9M at Dec 31, 2025, raising working capital concerns.
• · The company drew $60M from its revolving credit facility in H1 2026, with no repayments, increasing debt.
• · Customer A concentration increased to 18.9% of revenue and 33.3% of accounts receivable in 2026 from 17.5% and 25.2% respectively in 2025.
• · A $5.3M litigation settlement expense was recorded in H1 2026, with no comparable item in H1 2025.
• · Diluted EPS declined to $0.07 in Q2 2026 from $0.08 in Q2 2025.

04-08-2026

Global Business Travel Group, Inc. (GBTG) reported revenue of $870M for Q2 2026, up 38% YoY from $631M in Q2 2025, and $1,710M for H1 2026, up 37% from $1,252M in H1 2025. However, operating income declined to $24M in Q2 2026 from $34M in Q2 2025, and H1 2026 operating income fell sharply to $27M from $89M in H1 2025, driven by a 431% surge in restructuring charges to $41M (Q2) and $85M (H1). Net income attributable to common stockholders was $15M in Q2 2026 (flat vs. $13M in Q2 2025) but dropped 24% for H1 2026 to $67M from $88M in H1 2025. Cash from operations improved to $127M in H1 2026 from $110M in H1 2025, while the company repurchased $47M of common shares in H1 2026 versus just $1M in the prior year.

• · Total assets increased 3% to $5,077M as of June 30, 2026 from $4,916M at December 31, 2025.
• · Long-term debt, net increased 7% to $1,451M from $1,360M over the same period.
• · Accounts receivable rose to $968M (net) from $869M, with allowance for credit losses increasing to $11M from $9M.
• · Goodwill remained nearly flat at $1,663M vs. $1,671M.
• · Earnout derivative liabilities were eliminated to $0 from $37M at year-end 2025, reflecting settlement.
• · The company issued 399,976 shares to settle contingent consideration in Q2 2026.
• · Basic and diluted EPS were $0.03 for Q2 2026 (unchanged from Q2 2025) and $0.13 for H1 2026 vs. $0.19 in H1 2025.
• · Cash paid for income taxes was $0 in H1 2026 vs. $29M in H1 2025.
• · Proceeds from termination of interest rate swap contracts were $0 in H1 2026 vs. $31M in H1 2025.
• · The company had $29M in restricted cash as of June 30, 2026, down from $40M at December 31, 2025.

04-08-2026

Sensei Biotherapeutics reported a net loss of $16.0M for Q2 2026 and $186.2M for H1 2026, compared to $4.9M and $11.8M in the prior-year periods, driven by a $133.0M acquired in-process R&D charge from the acquisition of Faeth Therapeutics. Total operating expenses surged to $18.4M (Q2) and $189.0M (H1) from $5.2M and $12.5M a year earlier. However, the company strengthened its balance sheet significantly, ending June 2026 with $186.4M in cash, cash equivalents, and marketable securities versus $21.2M at year-end 2025, following a $200.0M private placement and the Faeth acquisition.

• · The company completed the acquisition of Faeth Therapeutics during H1 2026, recognizing $133.0M in acquired in-process R&D and $12.9M in net assets acquired.
• · A $200.0M private placement of Series B redeemable convertible preferred stock was completed, with $16.9M in issuance costs.
• · Substantially all Series B preferred stock (24,435 shares) was converted into 24,435,594 common shares during Q2 2026, leaving only 502 Series B shares outstanding.
• · Common shares outstanding surged from 1,261,685 at year-end 2025 to 25,832,969 at June 30, 2026, a 20.5x increase.
• · Stock-based compensation expense rose to $17.4M in H1 2026 from $0.7M in H1 2025, a 24x increase.
• · Interest income increased to $2.7M in H1 2026 from $0.7M in H1 2025, reflecting higher cash and investment balances.
• · Net loss per share improved from ($3.91) to ($2.84) in Q2 and from ($9.36) to ($53.50) in H1, with the H1 figure impacted by the large IPR&D charge.
• · The company's accumulated deficit grew 66% to $469.4M from $283.1M at year-end 2025.

04-08-2026

Pinnacle West Capital Corp reported net income attributable to common shareholders of $178.574M for Q2 2026, down 7.3% from $192.564M in Q2 2025, while for the first six months of 2026 net income rose 12.5% to $211.494M from $187.920M. Operating revenues increased 7.1% to $1.456B in Q2 2026, driven by higher fuel and purchased power costs, but operating income slipped slightly to $305.672M from $307.552M. The company's balance sheet expanded to $32.577B in total assets, with long-term debt rising to $9.776B, while cash flow from operations declined 5.1% to $629.272M for the six-month period.

• · Fuel and purchased power expenses rose 17.1% in Q2 2026 to $558.498M from $477.008M in Q2 2025.
• · Interest charges increased 17.7% in Q2 2026 to $133.601M from $113.527M in Q2 2025.
• · Capital expenditures for the first six months of 2026 were $1.357B, up from $1.332B in the prior year period.
• · Short-term borrowings increased to $818.6M as of June 30, 2026 from $757.005M at year-end 2025.
• · Current maturities of long-term debt rose to $775M from $600M at December 31, 2025.
• · Operating lease right-of-use assets increased significantly to $5.011B from $3.650B at year-end 2025.
• · Deferred fuel and purchased power regulatory asset was zero at June 30, 2026, down from $149.068M at December 31, 2025, while a corresponding liability of $61.437M was recorded.
• · Dividends per common share increased to $1.82 in Q2 2026 from $1.79 in Q2 2025.

04-08-2026

HNI Corp reported Q2 FY26 net sales of $1,472.4M, more than doubling from $667.1M in Q2 FY25, driven by the impact of a major acquisition. However, net income attributable to HNI only rose 6% to $51.1M from $48.2M, and on a year-to-date basis net income plunged 80% to $12.3M from $62.2M, reflecting significant acquisition-related costs, restructuring charges, and inventory step-up expenses. Operating cash flow turned negative at -$32.0M for the first half versus +$43.7M a year ago.

• · Q2 FY26 gross profit was $647.2M vs $286.2M in Q2 FY25, a 126% increase.
• · Selling and administrative expenses more than doubled to $533.0M from $215.5M.
• · Interest expense, net increased to $23.7M in Q2 FY26 from $6.1M in Q2 FY25, a 288% rise.
• · Total assets decreased slightly to $4,817.6M from $4,885.0M at year-start.
• · Total liabilities decreased to $3,012.4M from $3,049.5M.
• · Capital expenditures were $62.4M in H1 FY26 vs $30.3M in H1 FY25.
• · Dividends paid increased to $52.1M in H1 FY26 from $31.9M in H1 FY25.
• · No share repurchases occurred in H1 FY26 vs $79.8M in H1 FY25.

04-08-2026

LSEB Creative Corp. filed its 10-K annual report for the year ended March 31, 2026, reporting a net loss of $59,985, a significant improvement from the $160,011 net loss in the prior year. Revenue declined 12.8% to $17,906 from $20,537, but gross profit improved to $13,752 from $11,912 due to a sharp reduction in cost of goods sold. The company remains in a precarious liquidity position with cash of only $101 and a stockholders' deficiency of $20,490, though operating cash burn improved to $(42,909) from $(152,716).

• · The company's working capital is only $74,000, with planned expenses of $400,000 including $150,000 for advertising and marketing.
• · No stock-based compensation or share issuance occurred in FY2026, compared to $42,000 in stock-based compensation and $92,000 in share proceeds in FY2025.
• · The company's accumulated deficit grew to $774,530 from $714,545, and it has a stockholders' deficiency of $20,490 (negative equity).
• · Accounts receivable dropped to $0 from $8,067, and accrued liabilities dropped to $0 from $8,834.
• · The company is classified as a penny stock issuer with associated risk disclosures.